Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.

PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: City of Hope Medical Center
• Collaborator: National Cancer Institute (NCI)

Criteria

DISEASE CHARACTERISTICS:

• Diagnosis of ovarian cancer

• Under the care of the Medical Oncology Department at the City of Hope National Medical Center

• Undergoing intraperitoneal chemotherapy

PATIENT CHARACTERISTICS:

• Life expectancy > 6 months

• Speaks English or Spanish

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics